Skip to main content

Table 3 Deamidated peptides monitored and their contribution to the overall peptide areas and ratios

From: Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring

Protein/peptide

L/H ratio formula

(non-deamidated formula on top, total on bottom)

Heavy peptide deamidation  % (mean ± SD)

Light peptide deamidation  % (mean ± SD)

Mean peptide

 % Conc. ∆ due to deamidation

TSP1/GGVNDNFQGVLQNVR

\(\frac{808.9}{813.9}\)

33 ± 1.2

39 ± 6.5

6.5

\(\frac{808.9 + 809.4 + 809.4 + 809.4}{813.9 + 814.4 + 814.4 + 814.4}\)

BST1/GFFADYEIPNLQK

\(\frac{771.3}{775.3}\)

35 ± 0.8

44 ± 3.8

12

\(\frac{771.3 + 771.8 + 771.8 + 772.3}{775.3 + 775.8 + 775.8 + 776.3}\)

TSP1/TIVTTLQDSIR

\(\frac{623.8}{628.8}\)

28 ± 0.3

33 ± 3.7

7

\(\frac{623.8 + 624.3}{628.8 + 629.3}\)

RHOB/IQAYDYLECSAK

\(\frac{730.8}{734.8}\)

20 ± 0.9

15 ± 14.8

12

\(\frac{730.8 + 731.3}{734.8 + 735.3}\)

  1. Mean % of heavy peptide deamidations, % of light peptide deamidations and % change in concentration (due to the modified forms) for each peptide, and across all urine samples is shown